About STATKING Clinical Services
STATKING Clinical Services is a Healthcare company based in Fairfield (United States) founded in 1989, and was acquired by Genesis Biotechnology Group in January 2021. Clinical trial services are provided by STATKING Clinical Services. It operates on a Professional Services model. Its chief executive, as recorded, is Dennis King. STATKING Clinical Services offers products and services including Clinical Trial Management, Biostatistics, and Clinical Data Management. Its focus areas include Clinical Research and Contract Research Organization. Its competitors include BioAgilytix, Advion and Evans Analytical Group; 1 of its 3 listed competitors has raised funding.
Company details
STATKING Clinical Services is engaged in supporting drug discovery and development through clinical trial management. Services are offered across Phase I-III trials, covering biostatistics, data management, and medical writing. Expertise is provided in therapeutic areas like oncology, CNS, and rare diseases. Solutions are tailored for pharmaceutical and medical device industries, including feasibility and pivotal trials. The company is integrated with Genesis Drug Discovery Development (GD3) for comprehensive CRO services.
- Headquarters Fairfield, United States
- Stage Acquired
- SectorsHealthcare
- Website statkingclinical.com
- Social LinkedIn
- Acquired by Genesis Biotechnology Group (Jan 2021)
- InvestorsGenesis Biotechnology Group
& 1 more
- Acquired byGenesis Biotechnology Group
(Jan 2021)
Products & Services of STATKING Clinical Services
STATKING Clinical Services offers a comprehensive portfolio of products and services, including Clinical Trial Management, Biostatistics, and Clinical Data Management.
Clinical trials are managed for drug development phases.
Statistical analysis is provided for clinical trial data.
Data from clinical studies is organized and managed.
Investors in STATKING Clinical Services
STATKING Clinical Services has secured backing from 2 investors. Prominent investors backing the company include Genesis Biotechnology Group and Genesis Drug Discovery & Development.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A consortium of companies focused on improving patient care. | genesisbiotechgroup.com | Hamilton, United States | ||
A contract research organization focused on drug discovery and development. | gd3services.com | Hamilton, United States |
Investor details for STATKING Clinical Services
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of STATKING Clinical Services
1 people are tracked at STATKING Clinical Services (1 in leadership).
| Name | Role | Group |
|---|---|---|
Dennis King | CEO & President | Leadership |
Complete people profiles for STATKING Clinical Services
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of STATKING Clinical Services
2 dated milestones of STATKING Clinical Services across 32 years, from founding to its latest funding, stage changes and deals.
- Founded STATKING Clinical Services is founded.
- Exit Acquired by Genesis Biotechnology Group.
Competitors of STATKING Clinical Services
STATKING Clinical Services has 3 listed competitors in our database, 1 of them funded. They include BioAgilytix, Advion and Evans Analytical Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bioagilytix.com | 2008 | Durham, United States | 446 | Large-molecule bioanalysis is provided for biologics and biosimilars development. | ||
| advion.com | 1993 | Ithaca, United States | $45.64M | 54 | Microfluidics and mass spectrometry products are provided for clinical research. | |
| eag.com | 1978 | San Diego, United States | 601 | Company offering a suite of scientific services for materials, engineering, agri, and life science industries |
Detailed competitors of STATKING Clinical Services
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of STATKING Clinical Services
Websites that share an audience with STATKING Clinical Services (statkingclinical.com).
Websites whose visitors overlap most with STATKING Clinical Services. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| ephicacy.com | 100% | 13.6K | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as STATKING Clinical Services (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Statking Clinical Services
Complete news archive for STATKING Clinical Services
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about STATKING Clinical Services
STATKING Clinical Services was founded in 1989.
STATKING Clinical Services is headquartered in Fairfield, United States.
Dennis King is the CEO of STATKING Clinical Services, as recorded in our data.
STATKING Clinical Services is engaged in supporting drug discovery and development through clinical trial management. Services are offered across Phase I-III trials, covering biostatistics, data management, and medical writing. Expertise is provided in therapeutic areas like oncology, CNS, and rare diseases. Solutions are tailored for pharmaceutical and medical device industries, including feasibility and pivotal trials. The company is integrated with Genesis Drug Discovery Development (GD3) for comprehensive CRO services.
STATKING Clinical Services's top competitors include BioAgilytix, Advion and Evans Analytical Group.
STATKING Clinical Services offers Clinical Trial Management, Biostatistics, and Clinical Data Management.
STATKING Clinical Services has 2 investors. Key investors include Genesis Biotechnology Group, and Genesis Drug Discovery & Development.
Yes. STATKING Clinical Services was acquired by Genesis Biotechnology Group in January 2021.